Is Calcium Dobesilate compatible with breastfeeding? Do we have alternatives for Calcium Dobesilate?

Calcium Dobesilate

June 10, 2018 (Low Risk)

A drug to which the ability to reduce capillary permeability is attributed. Used to treat diabetic retinopathy and hemorrhoids.
Administered orally in two daily doses.

Since the last update we have not found published data on its excretion in breastmilk, although the manufacturer indicates negligible excretion in breastmilk (OMPharma 2018, AEMPS 2017).

As there is less published information than for other drugs from the same group, safer known alternatives may be preferable during the neonatal period and in case of prematurity.

Alternatives

Very Low Risk

Compatible. Not risky for breastfeeding or infant.

Low Risk

Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.

High Risk

Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.

Very High Risk

Not recommended. Cessation of breastfeeding or alternative.

Writings

  • Δοβεσυλικό ασβέστιο (Greek)
  • دوبيسيلات كالسيوم (Arabic)
  • Кальция Добезилат (Cyrillic)
  • 羟苯磺酸钙 (Chinese)
  • ドベシル酸カルシウム (Japanese)
  • Dobésilate de Calcium (French)
  • C12 H10 CaO10 S2 (Molecular formula)
  • Calcium 2,5-dihydroxybenzenesulphonate (Chemical name)
  • C05BX01 (ATC Code/s)

Drug trade names

References

  1. OM Pharma. Dobesilate. Drug Summary. 2018 Full text (in our servers)
  2. AEMPS. Dobesilato. Ficha técnica. 2017 Full text (in our servers)
  3. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, Capellà D, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2016Abstract